The three Swiss pharmaceutical associations, Interpharma, the VIPS and the SGCI/SSIC Chemie Pharma Schweiz, have combined on a public awareness program concerning drug R&D. As part of the campaign, a new web site has been launched (www.pharma-recherche.ch) and two television advertisements broadcast on Swiss television.
The web site is designed to provide data on drug R&D in a user-friendly format to the general public. The Interpharma said that "the major themes at the moment are age-related blindness, cancer, multiple sclerosis and cardiovascular diseases." The group added: "from December, interesting interviews with leading lights in the Swiss research field will be published at regular intervals in a streaming video format." An on-line bulletin will also be made available concerning new developments in Switzerland's pharmaceutical sector.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze